ArticleBioinformation2024

Decoding the anti-cancer potential of Pexidartinib (PLX3397), a Fms-like tyrosine kinase 3 inhibitor, using next-generation knowledge discovery methods.

Roaa Mahdi AlreemiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.